Search Results 181-190 of 422 for ❣베스트토토검증【평생베스트.com】베스트토토❣

  1. Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

    This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...

  3. Essential Thrombocythemia Clinical Trials - Mayo Clinic Research

    This phase I/IB trial studies the side effects, best dose, and efficacy of azacitidine and erismodegib in treating patients with myeloid malignancies. The ...

  4. Neurology - Clinical trials - Mayo Clinic

    By comparing the gene expression of motor neurons derived from iPSC cells of phenotypically discordant Spinal Muscular Atrophy (SMA) sibling pairs and ...

  5. ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 19-002650. NCT ID: NCT03973372. Sponsor Protocol Number: STU00208288. About this study. ALTA is a multicenter ...

  6. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. Hematology - Clinical trials

    This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta ...

  8. An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    About this study. In pancreatic cancer, targeting the tumor microenvironment has become a promising therapeutic strategy. Focal adhesion kinase (FAK) ...

  10. Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform - Mayo Clinic

    ... best. Study IDs. Site IRB. Jacksonville, Florida: 23-008413. NCT ID: NCT06349642. Sponsor Protocol Number: MC230901. About this study. The purpose of this study ...